Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: Japan Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20092
20111
20121
20152
20163
20171
20191
20202
20212
20224
20233
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting8
Terminated5
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
AbbVie3
Amgen3
Eli Lilly and Company3
AstraZeneca2
Seagen, a wholly owned subsidiary of Pfizer2
Bayer1
EMD Serono Research & Development Institute, Inc.1
Eisai Co., Ltd.1
Elevation Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms31
Carcinoma, Non-Small-Cell Lung13
Colorectal Neoplasms9
Esophageal Neoplasms8
Neoplasm Metastasis7
Neoplasms7
Squamous Cell Carcinoma of Head and Neck7
Breast Neoplasms6
Ovarian Neoplasms6
Triple Negative Breast Neoplasms6

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.